Capricorn Fund Managers Ltd Purchases Shares of 19,404,192 The Beauty Health Company $SKIN

Capricorn Fund Managers Ltd purchased a new position in The Beauty Health Company (NASDAQ:SKIN) during the 1st quarter, according to its most recent 13F filing with the SEC. The firm purchased 19,404,192 shares of the company’s stock, valued at approximately $17,270,000. Beauty Health comprises 2.7% of Capricorn Fund Managers Ltd’s investment portfolio, making the stock its 10th largest position. Capricorn Fund Managers Ltd owned about 15.19% of Beauty Health as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the stock. AQR Capital Management LLC acquired a new position in shares of Beauty Health during the first quarter valued at about $40,000. Goldman Sachs Group Inc. lifted its stake in shares of Beauty Health by 5.0% in the first quarter. Goldman Sachs Group Inc. now owns 665,706 shares of the company’s stock valued at $892,000 after buying an additional 31,880 shares during the period. Geode Capital Management LLC grew its position in Beauty Health by 27.5% during the second quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock worth $4,399,000 after buying an additional 496,963 shares in the last quarter. JPMorgan Chase & Co. grew its position in Beauty Health by 54.1% during the second quarter. JPMorgan Chase & Co. now owns 54,226 shares of the company’s stock worth $104,000 after buying an additional 19,032 shares in the last quarter. Finally, Rhumbline Advisers increased its stake in Beauty Health by 28.6% during the second quarter. Rhumbline Advisers now owns 141,982 shares of the company’s stock valued at $271,000 after acquiring an additional 31,565 shares during the period. Institutional investors own 93.26% of the company’s stock.

Beauty Health Stock Performance

NASDAQ SKIN opened at $0.69 on Wednesday. The Beauty Health Company has a twelve month low of $0.55 and a twelve month high of $2.69. The company has a quick ratio of 1.48, a current ratio of 1.79 and a debt-to-equity ratio of 4.37. The stock has a market cap of $89.75 million, a P/E ratio of -4.07 and a beta of 1.09. The company’s 50-day simple moving average is $0.72 and its 200 day simple moving average is $1.05.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.04. The firm had revenue of $64.91 million during the quarter, compared to analysts’ expectations of $66.28 million. Beauty Health had a negative net margin of 2.03% and a negative return on equity of 9.38%. As a group, research analysts forecast that The Beauty Health Company will post -0.14 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have commented on SKIN shares. Benchmark reaffirmed a “hold” rating on shares of Beauty Health in a report on Friday, March 13th. Canaccord Genuity Group decreased their price objective on Beauty Health from $1.50 to $1.00 and set a “hold” rating on the stock in a report on Friday, May 1st. Zacks Research upgraded Beauty Health from a “strong sell” rating to a “hold” rating in a research report on Monday, March 16th. TD Cowen cut their target price on Beauty Health from $1.65 to $1.50 and set a “hold” rating for the company in a research note on Monday, March 16th. Finally, Roth Mkm reaffirmed a “buy” rating and issued a $2.00 target price (down from $2.50) on shares of Beauty Health in a research report on Wednesday, May 20th. One research analyst has rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Beauty Health presently has an average rating of “Hold” and an average target price of $2.02.

Beauty Health Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.